Assessing Cognitive Performance Among Adults With Attention Disorders Working on Treadmill

Ariel University

Status and phase: Unknown; Phase 3; Phase 2

Conditions: Attention Deficit Disorder

Treatments: Drug: Methylphenidate; Device: Treadmill workstation

Study type: Interventional

Funder types: Other

Identifiers

NCT05243186

ArielUni

Details and patient eligibility

About

Randomized clinical trial in which individuals who have been diagnosed with ADHD and are regularly treated with Methylphenidate will be test for cognitive performance and will be randomly examined in the following four conditions:

• While taking Methylphenidate and sitting at a desk
• While taking Methylphenidate and walking on a treadmill workstation
• Without taking Methylphenidate while sitting at a desk
• Without taking Methylphenidate while walking on a treadmill workstation The investigators will compare the cognitive achievements outcomes and evaluate the efficiency of studying in each of these four conditions.

Full description

The rationale of this clinical trial is to identify the intervention that best contributes to better cognition results of adults with ADHD's: physical activity, drug or a combination of the two? The study will enable to determine which factor will improve cognitive results. The findings of this trial will help determine the best treatment method that can be offer to adults with ADHD.

Enrollment: 30 estimated patients

Sex: All

Ages: 20 to 60 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

* Insured by Maccabi Health Services

• Diagnosed with ADHD by Neurologist/Psychiatrist/Developmental Doctor
• Take Methylphenidate as part of the treatment for ADHD AND have agreed to not take the drug if asked to
• Understand the language and simple instruction
• Willing to participate in the study and sign the agreement form

Exclusion criteria

• Suffer from heart disease or chronic respiratory illness
• Women who are pregnant

Trial design

Primary purpose: Other

Allocation: Randomized

Interventional model: Crossover Assignment

Masking: None (Open label)

---

30 participants in 4 patient groups, including a placebo group

MPH walking

Experimental group

Description:

The participants will be instructed to work while taking Methylphenidate and walking on a treadmill workstation

Treatment:

Device: Treadmill workstation

Drug: Methylphenidate

MPH sitting

Placebo Comparator group

Description:

The participants will be instructed to work while taking Methylphenidate and sitting at a desk

Treatment:

Drug: Methylphenidate

No MPH walking

Placebo Comparator group

Description:

The participants will be instructed to work without taking Methylphenidate while walking on a treadmill workstation

Treatment:

Device: Treadmill workstation

No MPH sitting

Placebo Comparator group

Description:

The participants will be instructed to work without taking Methylphenidate while sitting at a desk

Treatment:

Device: Treadmill workstation

Drug: Methylphenidate